Comment on "Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer".
作者信息
Han Zihan, Gao Zhaoya, Chen Jiajia, Gao Qingkun, Lei Fuming, Gu Jin
机构信息
From the Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
Department of General Surgery, Peking University Shougang Hospital, Beijing, China.
出版信息
Ann Surg Open. 2022 Apr 15;3(2):e156. doi: 10.1097/AS9.0000000000000156. eCollection 2022 Jun.
Abstract
摘要
相似文献
1
Comment on "Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer".对“直肠癌完全缓解的观察等待前瞻性队列中局部复发的管理与结局”的评论
Ann Surg Open. 2022 Apr 15;3(2):e156. doi: 10.1097/AS9.0000000000000156. eCollection 2022 Jun.
2
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.放化疗后观察等待与手术切除治疗直肠癌患者的对比（OnCoRe 项目）：倾向评分匹配队列分析。
Lancet Oncol. 2016 Feb;17(2):174-183. doi: 10.1016/S1470-2045(15)00467-2. Epub 2015 Dec 17.
3
Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.新辅助放化疗后非手术治疗直肠癌局部复发患者的结局。
Dis Colon Rectum. 2022 Mar 1;65(3):333-339. doi: 10.1097/DCR.0000000000002197.
4
Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.直肠癌完全缓解后观察等待队列中局部复发病例的管理和结局。
Ann Surg. 2021 Dec 1;274(6):e1056-e1062. doi: 10.1097/SLA.0000000000003738.
5
Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.新辅助放化疗后完全临床缓解和观察等待的直肠癌局部复发：挽救治疗对局部疾病控制的影响。
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):822-8. doi: 10.1016/j.ijrobp.2013.12.012. Epub 2014 Feb 1.
6
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.新辅助治疗后完全缓解的直肠癌患者采用观察等待策略的评估。
JAMA Oncol. 2019 Apr 1;5(4):e185896. doi: 10.1001/jamaoncol.2018.5896. Epub 2019 Apr 11.
7
Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.新辅助放化疗后临床完全缓解的直肠癌患者行观察等待策略的肿瘤学和生存结局：系统评价和汇总分析。
Ann Surg. 2018 Dec;268(6):955-967. doi: 10.1097/SLA.0000000000002761.
8
A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.一种动态临床计算器，用于估算直肠癌全新辅助治疗后行手术或观察等待管理的条件无复发生存率。
JAMA Netw Open. 2022 Sep 1;5(9):e2233859. doi: 10.1001/jamanetworkopen.2022.33859.
9
A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.局部直肠癌放化疗后完全临床缓解者观察等待的纵向队列研究：研究方案。
BMC Cancer. 2022 Mar 1;22(1):222. doi: 10.1186/s12885-022-09304-x.
10
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.国际观察等待数据库中新辅助放化疗后观察等待管理的临床完全缓解者的无复发生存条件：一项回顾性、国际、多中心登记研究。
Lancet Oncol. 2021 Jan;22(1):43-50. doi: 10.1016/S1470-2045(20)30557-X. Epub 2020 Dec 11.
本文引用的文献
1
Surgery may not benefit patients with locally advanced rectal cancer who achieved clinical complete response following neoadjuvant chemoradiotherapy.对于在新辅助放化疗后达到临床完全缓解的局部晚期直肠癌患者，手术可能并无益处。
Asian J Surg. 2022 Jan;45(1):97-104. doi: 10.1016/j.asjsur.2021.03.025. Epub 2021 Apr 20.
2
Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation.淋巴管浸润而非浸润深度是早期结直肠癌转移的关键危险因素：前瞻性收集数据的回顾性基于人群队列研究，包括验证。
Ann Surg. 2022 Jan 1;275(1):e148-e154. doi: 10.1097/SLA.0000000000003854.
3
Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.直肠癌完全缓解后观察等待队列中局部复发病例的管理和结局。
Ann Surg. 2021 Dec 1;274(6):e1056-e1062. doi: 10.1097/SLA.0000000000003738.
4
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.直肠癌的器官保存（GRECCAR 2）：一项前瞻性、随机、开放标签、多中心、3 期临床试验。
Lancet. 2017 Jul 29;390(10093):469-479. doi: 10.1016/S0140-6736(17)31056-5. Epub 2017 Jun 7.
5
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.使用新辅助放化疗和局部切除对临床T2N0期低位直肠癌进行器官保留（ACOSOG Z6041）：一项开放标签、单臂、多机构的2期试验结果
Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22.
6
Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT.肿瘤退缩的碎片模式和侧向壁内扩散可能影响新辅助 CRT 后 TEM 治疗直肠癌的切缘适当性。
J Surg Oncol. 2014 Jun;109(8):853-8. doi: 10.1002/jso.23571. Epub 2014 Feb 12.
7
Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.单纯手术治疗伴或不伴盆腔侧壁清扫的低位直肠癌的疗效
Dis Colon Rectum. 2009 Apr;52(4):567-76. doi: 10.1007/DCR.0b013e3181a1d994.
8
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.放化疗后0期低位直肠癌的手术与非手术治疗：长期结果
Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8. doi: 10.1097/01.sla.0000141194.27992.32.
Zotero 插件